期刊名称：JOURNAL OF DIABETES AND ITS COMPLICATIONS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The primary purpose of Journal of Diabetes and its Complications is to act as a source of information, usable by those caring for patients with diabetes mellitus who are thereby at risk for development of those complications which all too often appear with time. While our primary aim is to assist the practitioner in his/her care of such patients, and to afford access to information that may allow the prevention of such complications, it is the Editors' wish to function as a forum for that information which, while still experimental, may shed light upon current thinking of those active in the fields appropriate to the aims of Journal of Diabetes and its Complications.
In addition to general articles on clinical aspects of diabetes mellitus, Journal of Diabetes and its Complications also presents articles on basic research in all areas of diabetes and its related syndromes. Topics covered relevant to the diabetic patient will include diagnosis, pathogenesis, and clinical management of: diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia. Journal of Diabetes and its Complications will also publish papers on the general pathogenesis and prevention of diabetes
|
|
Instructions to Authors
In addition to general articles on clinical aspects of diabetes mellitus, Journal of Diabetes and its Complications also presents articles on basic research in all areas of diabetes and its related syndromes. Topics covered relevant to the diabetic patient will include diagnosis, pathogenesis, and clinical management of: diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia. Journal of Diabetes and its Complications will also publish papers on the general pathogenesis and prevention of diabetes.
Criteria for initial considerations for papers submitted will be originality, statistical provability of all data, and applicability to the aims of the Journal as a whole. Additional weight will be afforded to those submissions that are concise and comprehensible. All potentially acceptable manuscripts will be subjected to the process of peer review. To aid with the peer review process, please include names, addresses, phone and fax numbers for individuals who might be able to review the manuscript.
To increase the usefulness of Journal of Diabetes and its Complications to the readership, submissions in the following categories, in addition to original manuscripts, will be deemed appropriate for consideration by the Editors and Editorial Board:
Editorials: Comments by organizations or individuals on topics of current interest.
Review Articles: Critical presentations of topics of interest to those active in the prevention and treatment of diabetes and its long-term complications.
Case Reports: Limited to the presentation and discussion of cases that help advance our understanding of diabetes and related syndromes.
Letters to the Editor: Responses to previous articles and editorials.
Announcements: Announcements to pertinent forthcoming meetings or events.
MANUSCRIPTS: Manuscripts should be typewritten, double-spaced, using a standard sized typeface and margins of at least one inch. Manuscripts should be submitted in Triplicate together with three copies of figures and tables. Xerographic copies are preferred to carbon copies for the duplicates. Manuscripts are accepted for publication with the understanding that their contents, or their essential substance, have not been published elsewhere, except in abstract form or by the express consent of the Editors. Materials taken from other sources must be accompanied by written permissions for reproduction, obtained from the original publisher. Statistical methods should be identified. Priority claims are discouraged.
Acknowledgments of aid or criticism should be approved by the person whose help is being recognized. Grantors may be listed at the conclusion of the text.
CONFLICT OF INTEREST POLICY: Authors are required to disclose commercial or similar relationships to products or companies mentioned in or related to the subject matter of the article being submitted. Sources of funding for the article should be acknowledged in a footnote on the title page. Affiliations of authors should include corporate appointments relating to or in connection with products or companies mentioned in the article, or otherwise bearing on the subject matter thereof. Other pertinent financial relationships, such as consultancies, stock ownership or other equity interests or patent-licensing arrangements, should be disclosed to the Editor-in-Chief in the cover letter at the time of submission. Such relationships may be disclosed in the Journal at the discretion of the Editor-in-Chief in footnotes appearing on the title page. Questions about this policy should be directed to the Editor-in-Chief.
TITLE PAGE: On the title page include title; subtitle (if any); first name, middle initial, and last names of each author, with academic degrees; name of Department(s) and Institution(s) to which the work should be attributed; disclaimer(s) (if any); name and address of author to whom requests for reprints should be sent. The address, telephone and fax numbers of the person responsible for negotiations concerning the manuscripts should be listed separately and clearly labeled as such. Authors will be required to sign a statement conferring the manuscript copyright to Journal of Diabetes and its Complications.
ABSTRACT AND KEY WORDS: An abstract of 100 to 250 words for articles (including reviews), or 50 to 100 words for brief communications or expanded abstracts, should be typed double-spaced on a separate page. It should cover the main factual points, including statements of the problem, methods, results, and conclusions. The abstract should be accompanied by a list of three to five key words for indexing purposes.
TEXT: Appropriate headings and subheadings should be provided in the methods, results, and discussion sections. Please keep the text clear and concise. Because the readership of Journal of Diabetes and its Complications spans many disciplines, jargon should be avoided, as it may not be familiar to some readers.
ABBREVIATIONS: Use standard abbreviations and units recommended in the Style Manual for Biological Journals (Fourth edition, Arlington, Va., American Institute of Biological Sciences, 1978). Nonstandard abbreviations should be defined the first time they appear in the text. A list of abbreviations is available in Uniform Requirements for Manuscripts submitted to Biological Journals, Annals of Internal Medicine 90:95-99, 1979.
DRUG NAMES Generic names should be used. Proprietary names may be given (parenthetically) with the first use of the generic name.
REFERENCES: References should be cited consecutively in the text as numbers enclosed in parentheses on the line of writing. The reference list should be typed double-spaced in the numerical order in which they are first cited in the text. The style of reference is that of Index Medicus, including end-page, but omitting number and month of issue. Accuracy of references is the responsibility of the author(s) and should be carefully rechecked before submission.
Examples:
For Journal Articles: Vitinghus E, Mogensen CE: Graded exercise and protein excretion in diabetic man and the effect of insulin treatment. Kid Int 21:725-729, 1982.
For Books: Brownlee M (ed), Diabetes Mellitus. New York, New York, Garland STMP Press, 1981.
For Articles in Books: Kohner EM: Assessment and treatment of diabetic retinopathy, in Brownlee M (ed), Diabetes Mellitus. New York, Garland STMP Press, 1981, pp. 117-212.
For Government Publications: Mackay BB (ed): Twelfth Annual Contractors Conference of the Artificial Kidney Program of the NIAMDD. Bethesda, Maryland, U.S. Government Printing Office (NIH publication No. 81-1979), 1979.
References to articles that are in press must state name of journal and, if possible, volume and year. References to unpublished material, if essential, should be incorporated in the appropriate place in the text. Written permission from authors of unpublished data should be obtained and submitted. Authors are responsible for the accuracy of the references. Please recheck all references before submission of the paper.
ILLUSTRATIONS: Illustrations should be professionally drawn and photographed. Submit three glossy prints of each photograph, figure, or drawing. Do NOT include headings or legends in the prints. Do not submit original artwork. Illustrations should be untrimmed, unmounted, and unstapled. Use black ink for all figures, charts, and line drawings. Make decimals, broken lines, symbols, and lettering large and strong enough for clear legible reproduction when reduced to one column width (approx 3") or two column width (7"). Do not combine very large type and very small type. Do not put crop marks or any other marks on photographs unless required for clarity of illustration (e.g., arrows). Label all illustrations clearly. Name(s) of authors, figure number, and the orientation of the top of the figure should always be noted on a LABEL affixed to the back of each illustration and never directly on the front or back of the glossy print. Number figures in the order in which they are mentioned in the text. Carefully consider proportion for each part of a multi-part figure. A vertically oriented 3 x 5" illustration cannot be combined with a horizontally oriented 5 x 3" illustration to produce a composite figure. Please note that art work will not be returned. Figure legends should be clearly labeled and typed, double-spaced, on a separate page.
TABLES: Tables should be typed, double-spaced, on separate sheets with number (Roman) and title. Symbols for units should be confined to column headings. Abbreviations should be kept to a minimum, and those used, explained.
REVIEW AND ACTION: All contributions (including solicited articles) are critically reviewed by the Editors, members of the Editorial Board, and/or appropriate consultant reviewers. Reviewers' comments are usually returned to authors. The decision of the Editors is final. Submit manuscripts to:
Philip Raskin, MD
Editor-in-Chief
Journal of Diabetes and its Complications
Department of Internal Medicine
The University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75235-8858, USA
Tel: (214)648-2017
Fax: (214)648-4854
E-mail: philip.raskin@utsouthwestern.edu
Editorial Board
-
- Editor-in-Chief:
- P. Raskin MD, University of Texas Southwestern Medical Center, Department of Internal Medicine, 5323 Harry Hines Blvd, Dallas, TX 75235, USA; Email: philip.raskin@utsouthwestern.edu
- European Co-Editor:
- C.E. Mogensen, Aarhus, Denmark
- Editorial Board:
- L. Baker, Philadelphia, PA, USA
G.L. Bakris, Chicago, IL, USA
R.A. DeFronzo, San Antonio, TX, USA
S.G. Gabbe, Seattle, WA, USA
J.E. Gerich, Rochester, NY, USA
N. Hotta, Nagoya, Japan
G. Jerums, Heidelberg, Australia
I. Jialal, Dallas, TX, USA
H. Keen, London, UK
M.D. Kerstein, Philadelphia, PA, USA
R. Kikkawa, Otsu, Japan
D. Lender, Dallas, TX, USA
J.B. Marks, Miami, FL, USA
S.M. Mauer, Minneapolis, MN, USA
H. Shamoon, Bronx, NY, USA
A. Sima, Ann Arbor, MI, USA
J.S. Skyler, Miami, FL, USA
S. Strowig, Dallas, TX, USA
G.C. Viberti, London, UK
P. Zimmet, Caulfield, Australia
|
